Cargando…
Clinical and diagnostic features of Bartter and Gitelman syndromes
BACKGROUND: Bartter and Gitelman syndromes are autosomal recessive disorders of renal tubular salt handling. Due to their rarity, limited long-term data are available to inform prognosis and management. METHODS: Long-term longitudinal data were analysed for 45 children with pathogenic variants in SL...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007694/ https://www.ncbi.nlm.nih.gov/pubmed/29942493 http://dx.doi.org/10.1093/ckj/sfx118 |
_version_ | 1783333080509972480 |
---|---|
author | Walsh, Patrick R Tse, Yincent Ashton, Emma Iancu, Daniela Jenkins, Lucy Bienias, Marc Kleta, Robert van’t Hoff, William Bockenhauer, Detlef |
author_facet | Walsh, Patrick R Tse, Yincent Ashton, Emma Iancu, Daniela Jenkins, Lucy Bienias, Marc Kleta, Robert van’t Hoff, William Bockenhauer, Detlef |
author_sort | Walsh, Patrick R |
collection | PubMed |
description | BACKGROUND: Bartter and Gitelman syndromes are autosomal recessive disorders of renal tubular salt handling. Due to their rarity, limited long-term data are available to inform prognosis and management. METHODS: Long-term longitudinal data were analysed for 45 children with pathogenic variants in SLC12A1 (n = 8), KCNJ1 (n = 8), CLCNKB (n = 17), BSND (n = 2) and SLC12A3 (n = 10) seen at a single centre between 1984 and 2014. Median follow-up was 8.9 [interquartile range (IQR) 0.7–18.1] years. RESULTS: Polyhydramnios and prematurity were seen in children with SLC12A1 and KCNJ1 mutations. Patients with CLCNKB mutations had the lowest serum potassium and serum magnesium and the highest serum bicarbonate levels. Fractional excretion of chloride was >0.5% in all patients prior to supplementation. Nephrocalcinosis at presentation was present in the majority of patients with SLC12A1 and KCNJ1 mutations, while it was only present in one patient with CLCNKB and not in SLC12A3 or BSND mutations. Growth was impaired, but within the normal range (median height standard deviation score −1.2 at the last follow-up). Impaired estimated glomerular filtration rate (eGFR <90 mL/min/1.73 m(2)) at the last follow-up was seen predominantly with SLC12A1 [71 mL/min/1.73 m(2) (IQR 46–74)] and KCNJ1 [62 mL/min/1.73 m(2) (IQR 48–72)] mutations. Pathological albuminuria was detected in 31/45 children. CONCLUSIONS: Patients with Bartter and Gitelman syndromes had a satisfactory prognosis during childhood. However, decreased eGFR and pathologic proteinuria was evident in a large number of these patients, highlighting the need to monitor glomerular as well as tubular function. Electrolyte abnormalities were most severe in CLCNKB mutations both at presentation and during follow-up. Fractional excretion of chloride prior to supplementation is a useful screening investigation in children with hypokalaemic alkalosis to establish renal salt wasting. |
format | Online Article Text |
id | pubmed-6007694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-60076942018-06-25 Clinical and diagnostic features of Bartter and Gitelman syndromes Walsh, Patrick R Tse, Yincent Ashton, Emma Iancu, Daniela Jenkins, Lucy Bienias, Marc Kleta, Robert van’t Hoff, William Bockenhauer, Detlef Clin Kidney J Rare Diseases BACKGROUND: Bartter and Gitelman syndromes are autosomal recessive disorders of renal tubular salt handling. Due to their rarity, limited long-term data are available to inform prognosis and management. METHODS: Long-term longitudinal data were analysed for 45 children with pathogenic variants in SLC12A1 (n = 8), KCNJ1 (n = 8), CLCNKB (n = 17), BSND (n = 2) and SLC12A3 (n = 10) seen at a single centre between 1984 and 2014. Median follow-up was 8.9 [interquartile range (IQR) 0.7–18.1] years. RESULTS: Polyhydramnios and prematurity were seen in children with SLC12A1 and KCNJ1 mutations. Patients with CLCNKB mutations had the lowest serum potassium and serum magnesium and the highest serum bicarbonate levels. Fractional excretion of chloride was >0.5% in all patients prior to supplementation. Nephrocalcinosis at presentation was present in the majority of patients with SLC12A1 and KCNJ1 mutations, while it was only present in one patient with CLCNKB and not in SLC12A3 or BSND mutations. Growth was impaired, but within the normal range (median height standard deviation score −1.2 at the last follow-up). Impaired estimated glomerular filtration rate (eGFR <90 mL/min/1.73 m(2)) at the last follow-up was seen predominantly with SLC12A1 [71 mL/min/1.73 m(2) (IQR 46–74)] and KCNJ1 [62 mL/min/1.73 m(2) (IQR 48–72)] mutations. Pathological albuminuria was detected in 31/45 children. CONCLUSIONS: Patients with Bartter and Gitelman syndromes had a satisfactory prognosis during childhood. However, decreased eGFR and pathologic proteinuria was evident in a large number of these patients, highlighting the need to monitor glomerular as well as tubular function. Electrolyte abnormalities were most severe in CLCNKB mutations both at presentation and during follow-up. Fractional excretion of chloride prior to supplementation is a useful screening investigation in children with hypokalaemic alkalosis to establish renal salt wasting. Oxford University Press 2018-06 2017-11-10 /pmc/articles/PMC6007694/ /pubmed/29942493 http://dx.doi.org/10.1093/ckj/sfx118 Text en © The Author 2017. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Rare Diseases Walsh, Patrick R Tse, Yincent Ashton, Emma Iancu, Daniela Jenkins, Lucy Bienias, Marc Kleta, Robert van’t Hoff, William Bockenhauer, Detlef Clinical and diagnostic features of Bartter and Gitelman syndromes |
title | Clinical and diagnostic features of Bartter and Gitelman syndromes |
title_full | Clinical and diagnostic features of Bartter and Gitelman syndromes |
title_fullStr | Clinical and diagnostic features of Bartter and Gitelman syndromes |
title_full_unstemmed | Clinical and diagnostic features of Bartter and Gitelman syndromes |
title_short | Clinical and diagnostic features of Bartter and Gitelman syndromes |
title_sort | clinical and diagnostic features of bartter and gitelman syndromes |
topic | Rare Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007694/ https://www.ncbi.nlm.nih.gov/pubmed/29942493 http://dx.doi.org/10.1093/ckj/sfx118 |
work_keys_str_mv | AT walshpatrickr clinicalanddiagnosticfeaturesofbartterandgitelmansyndromes AT tseyincent clinicalanddiagnosticfeaturesofbartterandgitelmansyndromes AT ashtonemma clinicalanddiagnosticfeaturesofbartterandgitelmansyndromes AT iancudaniela clinicalanddiagnosticfeaturesofbartterandgitelmansyndromes AT jenkinslucy clinicalanddiagnosticfeaturesofbartterandgitelmansyndromes AT bieniasmarc clinicalanddiagnosticfeaturesofbartterandgitelmansyndromes AT kletarobert clinicalanddiagnosticfeaturesofbartterandgitelmansyndromes AT vanthoffwilliam clinicalanddiagnosticfeaturesofbartterandgitelmansyndromes AT bockenhauerdetlef clinicalanddiagnosticfeaturesofbartterandgitelmansyndromes |